AI (artificial intelligence) is rapidly gaining traction in mental health care, and for good reason. It offers the potential to streamline care, uncover clinical insights, and broaden access to ...

In the last decade, gabapentin has quietly become one of the most commonly prescribed medications in the United States. What started as a treatment for seizures and nerve pain has expanded far beyond ...

Evidence from real-world studies and a 2024 survey revealed that the use of doxycycline as postexposure prophylaxis (PEP) for sexually transmitted infections (STIs) in Spain is expanding beyond ...

Developers of a lab-grown blood vessel designed to save life and limb in emergency scenarios appear to be promoting its use in surgeries far beyond what the Food and Drug Administration has approved ...

The US Food and Drug Administration (FDA) held a 2-day public hearing this week to solicit input about the marketing and use of medications and medical devices for off-label use. It is fairly common ...

Off-label treatments are offering new hope to children battling inflammatory bowel disease (IBD), especially when conventional therapies fall short. A comprehensive new review explores the real-world ...